Treatment frontiers.
Smith
Kerri
K
D058917:Adenosine A2 Receptor Antagonists; D000978:Antiparkinson Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D064987:Cell- and Tissue-Based Therapy; D046690:Deep Brain Stimulation; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000628:therapy; D012106:Research / Q000639:trends
D058917:Adenosine A2 Receptor Antagonists; D000978:Antiparkinson Agents; D007980:Levodopa